Health and Healthcare

Aytu Biopharma : AYTU

AYTU

Stock Data

$2.61

$0.03 (1.16%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.

All Aytu Biopharma Articles

14 Articles

Jon C. Ogg | Jul 2, 2020 at 8:45 AM EDT

Surging COVID-19 Cases Could Alter Aytu BioScience’s Path to Profitability

Some small companies are destined to be small forever. Others can grow into huge companies over time. What will be…

Chris Lange | Jun 10, 2020 at 1:53 PM EDT

Why Aytu BioScience Stock Remains a Promising Coronavirus Play

Aytu BioScience is a coronavirus play after moving into testing and treatment.

Chris Lange | Jun 3, 2020 at 12:54 PM EDT

Will All Those Deals Pay Off for Aytu BioScience Stock?

Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.

Chris Lange | May 29, 2020 at 11:35 AM EDT

The Path to Profitability for Aytu BioScience Stock

Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.

Chris Lange | May 11, 2020 at 12:55 PM EDT

COVID-19 Testing Continues to Lift Aytu BioScience Stock

This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with…

Paul Ausick | Apr 30, 2020 at 10:45 AM EDT

Can Atyu Bioscience Deliver on COVID-19 Treatments?

Aytu Bioscience has moved very quickly, both to execute agreements for products that can have an impact on the COVID-19…

Chris Lange | Apr 27, 2020 at 10:19 AM EDT

Aytu BioScience Reemphasizes Coronavirus Stock Status With Potential Treatment

Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus…

Chris Lange | Apr 16, 2020 at 7:31 AM EDT

Aytu BioScience Stock: Developments in Denver

Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending…

Paul Ausick | Mar 30, 2020 at 1:09 PM EDT

Will Increased COVID-19 Competition Hurt Aytu Biosciences Stock?

There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on…

Chris Lange | Mar 24, 2020 at 10:11 AM EDT

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal…

Chris Lange | Mar 23, 2020 at 7:05 AM EDT

Aytu BioScience Soars, Pending Approval of Coronavirus Test

Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen…

Paul Ausick | Mar 16, 2020 at 1:13 PM EDT

Why Coronavirus Test Competition Shocked Aytu Bioscience Stock

Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a…

Jon C. Ogg | Mar 10, 2020 at 2:18 PM EDT

The Coronavirus Diagnostics Trade Gets a New Stock Favorite

It is not a new scenario where an illness or problem starts to become a big deal in the public…

Chris Lange | Mar 10, 2020 at 11:10 AM EDT

Coronavirus Stocks Seeing the Biggest Bounce Back

More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at…